Bioadaptives Income Statement (2013-2025) | BDPT

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter)
0.00M0.01M0.01M0.00M0.01M0.00M0.00M0.00M0.00M0.00M0.02M0.01M0.01M675.000.00M0.00M0.01M
Cost of Revenue (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M849.000.01M0.00M0.01M246.000.00M781.000.00M
Gross Profit (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M429.000.00M0.00M0.01M
Operating items
Amortization - Intangibles (Quarter)
0.03M0.04M0.04M0.03M0.02M0.00M684.00669.00677.000.04M-0.01M0.00M0.02M
Depreciation & Amortization - Total (Quarter)
Selling, General & Administrative (Quarter)
0.01M0.03M0.11M0.12M0.11M0.09M0.04M0.02M0.01M0.01M0.03M0.04M0.03M0.00M0.04M0.26M0.14M0.20M0.25M0.23M
Other Operating Expenses (Quarter)
0.21M0.04M0.07M0.06M0.07M0.06M0.04M0.01M0.01M0.04M0.06M0.02M0.02M0.09M0.08M0.08M0.11M0.08M0.02M0.03M
Operating Expenses (Quarter)
0.22M0.07M0.18M0.18M0.18M0.15M0.08M0.03M0.02M0.06M0.10M0.06M0.05M0.09M0.12M0.34M0.25M0.28M0.27M0.26M
Operating Income (Quarter)
-0.21M-0.07M-0.17M-0.18M-0.17M-0.14M-0.08M-0.03M-0.02M-0.06M-0.09M-0.06M-0.05M-0.09M-0.12M-0.34M-0.25M-0.28M-0.27M-0.25M
EBIT (Quarter)
-0.21M-0.07M-0.17M-0.18M-0.17M-0.14M-0.08M-0.03M-0.02M-0.06M-0.09M-0.06M-0.05M-0.09M-0.12M-0.34M-0.25M-0.28M-0.27M-0.25M
Non-operating items
Non Operating Investment Income (Quarter)
0.00M-0.00M-423.00-148.00-21.00-106.00-31.0010.00-10.00-10.00-11.00-11.00
Other Non Operating Income (Quarter)
-0.05M-0.22M0.14M0.09M-0.19M-0.01M-0.22M-0.04M0.08M-0.32M-0.26M-0.09M0.08M0.05M0.12M0.10M0.03M
Non Operating Income (Quarter)
-0.28M-0.24M0.14M-0.04M-0.19M-0.08M-0.20M-975.00-0.27M-0.09M0.08M-0.21M-0.26M-0.09M0.08M-0.03M0.05M0.12M-0.11M-0.58M
Net income details
EBT (Quarter)
-0.49M-0.31M-0.03M-0.09M-0.37M-0.22M-0.17M-0.28M-0.03M-0.11M-0.11M0.02M-0.06M-0.18M-0.04M-0.37M-0.26M-0.16M-0.38M-0.82M
Profit After Tax (Quarter)
-0.49M-0.31M-0.03M-0.21M-0.37M-0.22M-0.28M-0.03M-0.29M-0.14M-0.01M-0.27M-0.31M-0.18M-0.04M-0.37M-0.20M-0.16M-0.38M-0.82M
Income from Continuing Operations (Quarter)
-0.49M-0.31M-0.03M-0.09M-0.37M-0.22M-0.17M-0.28M-0.03M-0.11M-0.11M0.02M-0.06M-0.18M-0.04M-0.37M-0.26M-0.16M-0.38M-0.82M
Consolidated Net Income (Quarter)
-0.49M-0.31M-0.03M-0.09M-0.37M-0.22M-0.17M-0.28M-0.03M-0.11M-0.11M0.02M-0.06M-0.18M-0.04M-0.37M-0.26M-0.16M-0.38M-0.82M
Income towards Parent Company (Quarter)
-0.49M-0.31M-0.03M-0.09M-0.37M-0.22M-0.17M-0.28M-0.03M-0.11M-0.11M0.02M-0.06M-0.18M-0.04M-0.37M-0.26M-0.16M-0.38M-0.82M
Net Income towards Common Stockholders (Quarter)
-0.49M-0.31M-0.03M-0.09M-0.37M-0.22M-0.17M-0.28M-0.03M-0.11M-0.11M0.02M-0.06M-0.18M-0.04M-0.37M-0.26M-0.16M-0.38M-0.82M
Additional items
EPS (Basic) (Quarter)
-0.02-0.010.000.00-0.010.000.000.000.000.000.00-0.120.000.000.00-0.11-3.46-0.02-0.03-0.07
EPS (Weighted Average and Diluted) (Quarter)
-0.040.060.00-0.04-0.020.02-0.04-0.07
Shares Outstanding (Weighted Average) (Quarter)
28.15M33.03M31.69M33.74M53.71M67.55M77.62M106.01M267.43M441.74M482.80M5.97M980.26M895.76M1,147.56M8.22M0.07M9.95M10.94M12.01M
Shares Outstanding (Diluted Average) (Quarter)
7.70M3.68M8.21M8.22M9.05M9.53M9.42M10.07M
EBITDA (Quarter)
-0.21M-0.07M-0.17M-0.18M-0.17M-0.14M-0.08M-0.03M-0.02M-0.06M-0.09M-0.06M-0.05M-0.09M-0.12M-0.34M-0.25M-0.28M-0.27M-0.25M
Interest Expenses (Quarter)
0.06M0.02M0.06M-0.09M0.03M0.08M0.09M0.25M0.01M0.05M0.02M-0.08M0.01M0.02M0.01M-0.04M0.01M0.01M0.01M0.01M